Advertisement

Topics

Maas Biolab, Inc. Company Profile

04:09 EDT 25th June 2018 | BioPortfolio

Maas Biolab is a neuropharmaceutical company developing a treatment- the use of cyclosporins as neuro-protectants- for chronic neurodegenerative diseases including amyotrophic lateral sclerosis, Alzheimer's, Parkinson's and Huntington's.
NeuroPharma AB, a Maas Biolab Swedish partner, is developing cyclosporin for treatment of the acute neurological indications of stroke, spinal trauma, and traumatic brain injury.

Maas Biolab’s patent and related intellectual property rights consist of "new use" patents, formulation patents and production patents for cyclosporins as neuroprotective agents issued or pending in the USA, Canada, Australia, New Zealand, and ARIPO (Africa), Europe (EPO), Japan, China, Russia and Mexico.

Members of the cyclosporin family display powerful neuroprotective properties in neuro-degeneration by preventing or reducing neuron cell death, by blocking critical enzymes and free radicals and protecting the mitochondria. Pre-clinical studies show cyclosporin-A to be the most powerful known neuroprotectant in ALS with promise also in Alzheimer's, Huntington's, and Parkinson's diseases.

Location

1155 University Blvd. SE
Albuquerque
New Mexico
87106
United States of America

Contact

Phone: 1 (505) 843-4230
Fax: 1 (505) 246-2891
Email: michael@maasbiolab.com


News Articles [5 Associated News Articles listed on BioPortfolio]

Affordable biolab spaces now available in Shepherd’s Bush

Affordable biolab spaces are now available at the Old Laundry Yard in Shepherd’s Bush Market thanks to a partnership between Open Cell, U+I and the London Borough of Hammersmith and Fulham and Synbi...

German minister wants to rebuild trust with Russia after spy standoff

German Foreign Minister Heiko Maas wants to resume dialogue with Russia and gradually improve ties after diplomatic expulsions over a nerve agent attack on a former Russian spy in England that Britain...

Open Cell launches shipping container labs to accelerate biotech start-up businesses

Open Cell has joined forces with regeneration specialist, U+I, and the London Borough of Hammersmith and Fulham and SynbiCITE to launch a biolab to offer affordable spaces at the Old Laundry Yard in S...

Open Cell launches shipping container labs at Shepherd's Bush Market to accelerate biotech start-up businesses

London, UK, 6th June 2018 / Sciad Newswire / Open Cell has joined forces with regeneration specialist, U+I, and the London Borough of Hammersmith and Fulham and SynbiCITE to launch a biolab to offer...

Global Expandable Graphite Market Research Report 2018 [Report Updated: 09012018] Prices from USD $3500

SummaryMarket Segment as follows:By Region AsiaPacific Segment by Company, Type and Application North America Segment by Company, Type and Application Europe Segment by Company, Type and Appl...

Drugs and Medications [0 Results]

None

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

A Comparative Review of Marketing Authorization Decisions in Switzerland, the EU, and the USA.

In this study we compared Swissmedic's (SMC's) regulatory marketing authorization decisions to those of the US Food and Drug Administration (FDA) and European drug regulatory authorities (EU). We inve...

Photosynthetic production of sunscreen shinorine using an engineered cyanobacterium.

Mycosporine-like amino acids (MAAs) are secondary metabolites of a variety of marine organisms including cyanobacteria and macroalgae. These compounds have strong ultraviolet (UV) absorption maxima be...

Contextual Exploration of a New Family Caregiver Support Concept for Geriatric Settings Using a Participatory Health Research Strategy.

Family caregivers are the backbone of the long-term care support system within the home environment. Comprehensive caregiver support programs require collaboration and coordination within the system. ...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Dietary Intervention, Gestational Weight Gain and Gestational Diabetes.

The aim of this pilot study is to conduct a dietary intervention for overweight (body maas index BMI≥25) and obese (BMI≥30) pregnant women in two maternity care clinics and explore the...

Trial Evaluating Folic Acid Supplementation by Concomitant Administration of Ethinyl Estradiol + Levonorgestrel

This trial evaluated folic acid supplementation after oral administration of the ethinyl estradiol + levonorgestrel + folic acid (0.02 mg + 0.10 mg + 0.4 mg) coated tablet (Level-Fol® Bio...

Androgen Responses to hCG and Ovarian Morphology in PCOS

Rationale and Hypothesis We have previously reported that theca cells (TC) responses to hCG in women with PCOS represent a spectrum where some exhibit exaggerated increases of 17OHP while ...

Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis

This study is designed as a prospective cohort study to evaluate the potential of diagnostic procedures in defining populations of patients self-reporting unexpected and uncontrollable epi...

Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate

This clinical trial evaluated the comparative bioavailability of two injectable suspension formulations of medroxyprogesterone acetate + estradiol cypionate, a test (Depomês®, 25 mg/mL m...

Companies [9 Associated Companies listed on BioPortfolio]

Maas Biolab LLC

Maas Biolab is a private pharmaceutical company in Albuquerque, N.M., USA, developing Mitogard®, the only cyclosporine formula designed for CSF delivery, to treat amyotrophic l...

Maas Biolab, LLC

Maas Biolab is a private pharmaceutical company in Albuquerque, New Mexico, USA, developing Mitogard®, the only cyclosporin formula designed for CSF delivery, to treat amyotrop...

Maas Biolab, Inc.

Maas Biolab is a neuropharmaceutical company developing a treatment- the use of cyclosporins as neuro-protectants- for chronic neurodegenerative diseases including amyotrophic lateral sclerosis, Alzhe...

Maas Companies Inc.

Maas & Peither GMP Verlag

nil

More Information about "Maas Biolab, Inc." on BioPortfolio

We have published hundreds of Maas Biolab, Inc. news stories on BioPortfolio along with dozens of Maas Biolab, Inc. Clinical Trials and PubMed Articles about Maas Biolab, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Maas Biolab, Inc. Companies in our database. You can also find out about relevant Maas Biolab, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Corporate Database Quicklinks



Searches Linking to this Company Record